...
首页> 外文期刊>Folia parasitologica >Induction of prominent Th1 response in C57Bl/6 mice immunized with an E.?coli-expressed multi T-cell epitope EgA31 antigen against Echinococcus granulosus
【24h】

Induction of prominent Th1 response in C57Bl/6 mice immunized with an E.?coli-expressed multi T-cell epitope EgA31 antigen against Echinococcus granulosus

机译:在大肠杆菌表达的针对细粒棘球E虫的多T细胞表位EgA31抗原免疫的C57Bl / 6小鼠中诱导显着的Th1反应

获取原文
           

摘要

First step in developing an epitope-based vaccine is to predict peptide binding to the major histocompatibility complex (MHC) molecules. We performed computational analysis of unique available EgA31 sequence to locate appropriate antigenic propensity positions. T-cell epitopes with best binding affinity values of & 50% inhibitory concentration were selected using different available servers (Propred and IEDB). Peptides with 100% population coverage were selected. A DNA fragment corresponding to the furin linker enriched in Golgi apparatus was inserted sequentially between each epitope sequences in a synthetic DNA in order to cleave the chimeric protein into four separated peptides. Subsequently, the synthetic DNA was cloned into the pGEX4T-1 and pEGFP-N1 vectors and GST-ChEgA31 was expressed in E. coli strain BL21-DE3. The recombinant protein was detected by western blotting using an HRP-conjugated polyclonal anti-GST antibody. Fusion protein purified by affinity chromatography was used to raise antisera in rabbits. Results in agar gel immunodiffusion assay indicated induction of specific antibodies against multiepitope antigen in the tested rabbits. Cytokine assay was carried out in C57Bl/6 mice and the levels of cytokines were analyzed by sandwich ELISA. Interestingly, production of specific IFN-γ was prominently higher in mice immunized with GST-ChEgA31 and pEGFP-ChEgA31 (650-1 300 pg/ml) compared to control groups. No difference was observed in the level of IL-10 and IL-4 in immunized and GST control group. Challenge study with 500 live protoscolices of Echinococcus granulosus on immunized mice demonstrated protectivity level (50-60%). Based on our results, it appeared that the chimeric protein in the study was able to stimulate T-helper cell-1 (Th1) development and high level of cell mediated immunity in mice.
机译:开发基于表位的疫苗的第一步是预测肽与主要组织相容性复合物(MHC)分子的结合。我们进行了独特的可用EgA31序列的计算分析,以找到适当的抗原倾向性位置。最佳结合亲和力值<3的T细胞表位。使用不同的可用服务器(Propred和IEDB)选择50%抑制浓度。选择具有100%人口覆盖率的肽。将与富集了高尔基体的弗林蛋白酶接头相对应的DNA片段顺序插入合成DNA中的每个表位序列之间,以将嵌合蛋白切割成四个分离的肽。随后,将合成的DNA克隆到pGEX4T-1和pEGFP-N1载体中,并在大肠杆菌BL21-DE3中表达GST-ChEgA31。使用结合了HRP的多克隆抗GST抗体,通过蛋白质印迹法检测了重组蛋白。通过亲和层析纯化的融合蛋白用于产生兔抗血清。琼脂凝胶免疫扩散测定法的结果表明在测试的兔子中诱导了针对多表位抗原的特异性抗体。在C57Bl / 6小鼠中进行细胞因子测定,并通过夹心ELISA分析细胞因子的水平。有趣的是,产生特异性IFN-γ。与对照组相比,在用GST-ChEgA31和pEGFP-ChEgA31免疫的小鼠中(650-1  300 pg / ml)明显更高。免疫组和GST对照组的IL-10和IL-4水平没有差异。在免疫小鼠上对500粒细棘球E的原球菌进行的攻毒研究表明其保护水平(50-60%)。根据我们的结果,似乎该研究中的嵌合蛋白能够刺激小鼠T辅助细胞1(Th1)的发育和高水平的细胞介导的免疫力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号